Article Per Year (5 Year)
p-Index From 2020 - 2025
0.408
P-Index
This Author published in this journals
All Journal JKKI : Jurnal Kedokteran dan Kesehatan Indonesia ABIS: Accounting and Business Information Systems Journal
Wijayana, Singgih
Unknown Affiliation
Economics, Econometrics & Finance Medicine & Pharmacology Public Health

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
Analisis Kinerja Tanggung Jawab Sosial dan Lingkungan Perusahaan dan Investasi Teknologi Informasi pada Nilai Perusahaan Nurulia, Pinkan Adhisa; Wijayana, Singgih
ABIS: Accounting and Business Information Systems Journal Vol 13, No 2 (2025): May
Publisher : Master in Accounting Program

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22146/abis.v13i2.107298

Abstract

Penelitian ini bertujuan untuk menganalisis pengaruh kinerja Tanggung Jawab Sosial dan Lingkungan dan Investasi Teknologi Informasi terhadap nilai perusahaan di perusahaan yang terdaftar di Bursa Efek Indonesia selama periode 2021-2023. Variabel kontrol yang digunakan meliputi leverage, profitabilitas, dan ukuran perusahaan. Penelitian ini menggunakan metode kuantitatif deskriptif dengan sampel perusahaan yang terdaftar di BEI dengan teknik secara purposive sampling. Data dianalisis menggunakan regresi linier berganda dengan perangkat lunak SPSS. Hasil penelitian ini menunjukkan bahwa kinerja TJSL dan ITI masing-masing memiliki pengaruh positif terhadap nilai perusahaan. Selain itu, secara bersamaan, kinerja TJSL dan ITI juga memberikan dampak positif terhadap nilai perusahaan. Hal ini dikarenakan, kombinasi TJSL yang kuat dan ITI yang tepat dapat memberikan perusahaan keunggulan kompetitif yang signifikan.
Assessment of one-year overall survival among stage III breast cancer patients Darwito; Sari, Ika Puspita; Wijayana, Singgih; Mahardinata, Nur Azid; Anwar, Sumadi Lukman; Ridhayani, Firda
JKKI : Jurnal Kedokteran dan Kesehatan Indonesia JKKI, Vol 16, No 2, (2025)
Publisher : Faculty of Medicine, Universitas Islam Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.20885/JKKI.Vol16.Iss2.art6

Abstract

Background: The results of a comprehensive diagnosis, combined with the individual's general state, establish the appropriate therapeutic care for breast cancer patients. These management disparities have an impact on clinical outcomes, which may influence patient survival. The evaluation process of breast cancer management is essential as a strategy to boost the therapy's effectiveness in the future year. Objectives: Assessing survival rate, one-year overall survival, among stage III breast cancer patients.Methods: An observational study was conducted comprising a retrospective cross-sectional study. Data collected retrospectively from the medical record followed a total sampling technique. This study included patients with breast cancer as a main diagnosis with or without comorbidities and aged ≥ 18 years when undergoing their first diagnosis. Moreover, the exclusion criteria were patients who had incomplete medical record data, undergoing breast cancer treatment at other healthcare facilities, unspecified clinical stage, and patients who had been diagnosed with non-stage III breast cancer. The survival time of the participants is defined as the number of months from initial diagnosis to their last status (alive, died, or loss of follow-up). One-year overall survival was projected using the Kaplan-Meier curve and presented as a percentage with a 95% confidence interval. Results: Of the 23 patients with stage III breast cancer and the mean age was 57.39 ± 10.417 years. The one-year overall survival for stage III breast cancer was 78.3%. In addition, metastases conditions were associated with worse one-year overall survival compared to patients without metastases (40.0% vs 88.9%, p=0.028).Conclusion: The survival rate of breast cancer patients remains lower than in another recent study from Indonesia. This indicates the requirement of treatment strategies evaluation.
Co-Authors Anwar, Sumadi Lukman Darwito Firda Ridhayani Ika Puspita Sari Mahardinata, Nur Azid Nurulia, Pinkan Adhisa